Document is current
Any future updates will be listed below
-
Authors
Meng, Yanxiang https://orcid.org/0000-0001-7447-9788
Horne, Christopher R. https://orcid.org/0000-0003-1318-514X
Samson, Andre L. https://orcid.org/0000-0002-0637-2716
Dagley, Laura F. https://orcid.org/0000-0003-4171-3712
Young, Samuel N.
Sandow, Jarrod J. https://orcid.org/0000-0001-5684-8236
Czabotar, Peter E. https://orcid.org/0000-0002-2594-496X
Murphy, James M. https://orcid.org/0000-0003-0195-3949
-
Funding
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council (2002965, 1079700, 1172929, 9000719)
- License Information
-
More Information
Article History
Received: 30 May 2022
Revised: 6 June 2022
Accepted: 8 June 2022
First Online: 23 June 2022
Competing interests
: YM, CRH, ALS, SNY, PEC and JMM contribute, or have contributed, to a project developing necroptosis inhibitors in collaboration with Anaxis Pharma Pty Ltd. The other authors declare no competing interests.
